John S James

592 total citations
49 papers, 168 citations indexed

About

John S James is a scholar working on Genetics, Infectious Diseases and Hematology. According to data from OpenAlex, John S James has authored 49 papers receiving a total of 168 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 8 papers in Infectious Diseases and 8 papers in Hematology. Recurrent topics in John S James's work include Hemoglobinopathies and Related Disorders (10 papers), Iron Metabolism and Disorders (8 papers) and Prenatal Screening and Diagnostics (4 papers). John S James is often cited by papers focused on Hemoglobinopathies and Related Disorders (10 papers), Iron Metabolism and Disorders (8 papers) and Prenatal Screening and Diagnostics (4 papers). John S James collaborates with scholars based in United States, United Kingdom and Saudi Arabia. John S James's co-authors include David C. Rees, Baba Inusa, Elizabeth Dormandy, Jeffrey C. Page, Timothy R. Graham, David T. Richens, P.G. Turner, Hettie Till, Wasil Jastaniah and Jincy Paulose and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PEDIATRICS.

In The Last Decade

John S James

43 papers receiving 157 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John S James United States 6 56 44 27 21 20 49 168
Emily M. Huebner United States 8 19 0.3× 52 1.2× 51 1.9× 18 0.9× 13 0.7× 20 196
Henrik Hjalgrim Denmark 11 36 0.6× 56 1.3× 72 2.7× 57 2.7× 18 0.9× 17 266
Alexander Woodman Saudi Arabia 6 17 0.3× 22 0.5× 20 0.7× 16 0.8× 9 0.5× 25 175
Behin Yektashenas United States 4 69 1.2× 103 2.3× 23 0.9× 15 0.7× 5 0.3× 9 260
Pierre L Yong United States 8 29 0.5× 52 1.2× 22 0.8× 17 0.8× 4 0.2× 21 306
Reena K. Gulati United States 7 79 1.4× 57 1.3× 12 0.4× 32 1.5× 5 0.3× 14 164
Cleandro Pires de Albuquerque Brazil 9 21 0.4× 47 1.1× 47 1.7× 6 0.3× 5 0.3× 41 231
Anna Marie P. Young United States 9 21 0.4× 5 0.1× 38 1.4× 28 1.3× 13 0.7× 27 293
Andrea Di Palma Italy 10 140 2.5× 149 3.4× 15 0.6× 38 1.8× 7 0.3× 20 248
Roya Nikbakht Iran 10 21 0.4× 24 0.5× 40 1.5× 12 0.6× 5 0.3× 33 252

Countries citing papers authored by John S James

Since Specialization
Citations

This map shows the geographic impact of John S James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S James more than expected).

Fields of papers citing papers by John S James

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John S James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S James. The network helps show where John S James may publish in the future.

Co-authorship network of co-authors of John S James

This figure shows the co-authorship network connecting the top 25 collaborators of John S James. A scholar is included among the top collaborators of John S James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John S James. John S James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bottle, Alex, S.B. Carr, Carl Reynolds, et al.. (2025). Indicators of inequity in research and funding for sickle cell disease, cystic fibrosis and haemophilia: a descriptive comparative study. The Lancet Haematology. 12(10). e789–e797.
2.
Montalembert, Mariane de, Fernando Ferreira Costa, Baba Inusa, et al.. (2024). Sickle Cell Health Awareness, Perspectives, and Experiences (SHAPE) survey: Perspectives of adolescent and adult patients, caregivers, and healthcare professionals on the burden of sickle cell disease. European Journal Of Haematology. 113(2). 172–182. 2 indexed citations
3.
James, John S, Biree Andemariam, Baba Inusa, et al.. (2020). Global Treatment Satisfaction Levels and Treatment Patterns from the International Sickle Cell World Assessment Survey (SWAY): Hydroxyurea (HU) Versus No HU. Blood. 136(Supplement 1). 8–10. 2 indexed citations
4.
James, John S & Elizabeth Dormandy. (2019). Improving Screening Programmes for Sickle Cell Disorders and Other Haemoglobinopathies in Europe: The Role of Patient Organisations. International Journal of Neonatal Screening. 5(1). 12–12. 1 indexed citations
5.
James, John S, Biree Andemariam, Baba Inusa, et al.. (2019). Management Strategies and Satisfaction Levels in Patients with Sickle Cell Disease: Interim Results from the International Sickle Cell World Assessment Survey (SWAY). Blood. 134(Supplement_1). 1017–1017. 3 indexed citations
6.
Richens, David T., et al.. (2015). Racial and Gender Influences on Pass Rates for the UK and Ireland Specialty Board Examinations. Journal of surgical education. 73(1). 143–150. 15 indexed citations
8.
James, John S. (2006). Patterns of Quick-Relief and Long-term Controller Medication Use in Pediatric Asthma. PEDIATRICS. 118(Supplement_1). S34–S35. 1 indexed citations
9.
James, John S. (2005). PA-457, new kind of antiretroviral: ten-day clinical trial results.. PubMed. 7–8. 1 indexed citations
10.
James, John S. (2005). Communication in a disaster: success of text messages.. PubMed. 4–5. 1 indexed citations
11.
James, John S. (2005). FDA, companies test RFID tracking to prevent drug counterfeiting.. PubMed. 5–8. 5 indexed citations
12.
James, John S. (2005). Uganda study found that death reduced HIV prevalence; did the public take home the wrong message?. PubMed. 5–6. 2 indexed citations
13.
James, John S. (2004). Atherosclerosis risk increased with HIV; treatment effects unclear.. PubMed. 4–5. 2 indexed citations
14.
James, John S. (2003). First AIDS vaccine tested did not protect, but gives scientific leads.. PubMed. 6–6. 4 indexed citations
15.
James, John S. (2002). Barcelona: visa barriers may disrupt conference.. PubMed. 4–5, 1. 2 indexed citations
16.
James, John S. (2002). Drug patents and developing countries: problems remain.. PubMed. 6–6. 1 indexed citations
17.
James, John S. (1999). The Mechanisms and the Spread of Antibiotic Resistance. Pediatric Annals. 28(7). 446–452.
18.
James, John S & Jeffrey C. Page. (1994). Painful diabetic peripheral neuropathy. A stepwise approach to treatment. Journal of the American Podiatric Medical Association. 84(9). 439–447. 10 indexed citations
19.
James, John S, et al.. (1987). The Political Offense Exception: Is the United States-United Kingdom Supplementary Extraditon Treaty the Beginning of the End?. American University international law review. 2(1). 4. 2 indexed citations
20.
James, John S. (1978). FORTH for microcomputers. ACM SIGPLAN Notices. 13(10). 33–39. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026